Why Viking Therapeutics Stock Popped Again Today Cantor Fitzgerald thinks the GLP-1 diet drug VK2735 will be a "multi-blockbuster" for Viking stock.
Abeona Therapeutics’ Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin Disease ZEVASKYN is expected to be available beginning in the third quarter of 2025 through ZEVASKYN Qualified Treatment Centers, located across the U.S. with experience in cell and gene therapy.
Unlocking ASX Trading Success - Insurance Australia Group The analysis aims to provide valuable insights into market trends and potential opportunities.
Why Shift4 Payments Stock Popped Today Despite "recent political commentary and capital markets volatility," Shift4 just had a great Q1.
Caterpillar Earnings Outlook Amid Trump Tariffs May Set Tone For Dow Jones Caterpillar earnings on Wednesday will offer a valuable window into the early fallout from Trump tariffs for the Dow Jones earthmoving giant.
Mastercard Bets On Cross-Border Payments With $300 Million Corpay Deal Mastercard and Corpay expand partnership to offer improved cross-border payment solutions, with Mastercard investing $300 million in Corpay's business.
EXCLUSIVE: Inside The Bond ETF That Thrives In Volatility—MacKay Shields' Zachary Aronson On How SECR Is Quietly Crushing It NYLI MacKay Securitized Income ETF (ARCA: SECR) offers institutional-quality exposure to RMBS, CMBS, and ABS with strong performance and yield.
Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance Novartis raises 2025 sales and profit forecast as key drugs drive strong Q1 results; core operating income up 23% to $5.6 billion on higher net sales.
Meta Launches AI App To Compete With ChatGPT, Gemini, Grok Meta Platforms Inc (
NASDAQ:META ) has announced the launch of a standalone AI app that will compete with the likes of OpenAI's ChatGPT, Google's Gemini and xAI's Grok.
Ecolab Navigates Soft Demand, Tariffs With Margin Gains, Confirms Full-Year Forecast Ecolab Inc. (
NYSE:ECL ) reported Q1 sales of $3.69 billion, down 2% Y/Y and missing consensus estimate of $3.70 billion. Organic sales grew 3% Y/Y.
Which S&P500 stocks are gapping on Tuesday? Looking for the S&P500 stocks that are experiencing notable gaps on Tuesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
Valero Energy Analyst Is No Longer Bearish: Here Are 3 Reasons Why Valero analyst Neil Mehta upgraded the rating from Sell to Neutral, while raising the price target from $115 to $127.
UNH: One Stock Superinvestors Are Loading Up On UnitedHealth Group is the largest healthcare company in the U.S. by revenue.
These stocks are gapping in today's session Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
PayPal Reports Better-Than-Expected Q1 Earnings But Flags Uncertainty In Global Macro Environment The company expects full-year adjusted EPS to be $4.95 to $5.10 and second-quarter earnings to be $1.29 to $1.31.
Zebra Stock Rises As Strong Retail Demand, Sales Beat Drive Big Quarter, But Tariffs Cloud Full-Year Outlook Zebra Technologies stock rises after reporting strong Q1 results, beating analyst estimates with $1.31B in sales and $4.02 EPS.
